Business Information
The group's principal activity is to develop clinical laboratory to offer routine cytogenetics testing and high-end molecular genetics services. The group serves human healthcare products industry. The group offers three types of genetic diagnostic services: cytogenetic testing, molecular biology testing and sponsored research services. Cytogenetic tests are routinely used to identify genetic abnormalities in pregnancy, as well as hematologic cancers. Sponsored research tests discovers underlying genetic causes of female diseases, cancers and other diseases of the ovary, uterus, cervix, and breast all have an underlying genetic basis. Molecular biology test includes dna tests used in the screening and diagnosis of single gene disorders and hematological cancers.
|
|
Name |
Title
|
Email
|
| Michael Dent | Chmn., CEO, Pres. | N/A | | Jerome Dvonch | Dir. - Finance, Principal Accounting Officer | N/A | | Robert Gasparini | Dir., Pres., Chief Science Officer | N/A | | Steven Jones | Dir., Acting Principal Financial Officer | N/A | | Matthew Moore | VP - Research, Development | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 6,476 | (130) | | 2005 | 1,885 | (997) | | 2004 | 558 | (819)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
